ArticleIrish journal of medical science2026
Serum neutrophil extracellular trap-related biomarkers for identifying cognitive impairment after mild traumatic brain injury.
Article in Irish journal of medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundCognitive impairment is a common sequela of mild traumatic brain injury (mTBI), but early blood-based predictors remain limited. Neutrophil extracellular traps (NETs) have been implicated in neuroinflammation after brain injury.
aimsWe investigated whether serum NET-related markers are associated with mild cognitive impairment (MCI) after mTBI and evaluated their utility for early risk stratification.
methodsA total of 157 patients with acute mTBI and 88 age- and sex-matched healthy controls (HCs) were enrolled in this retrospective cohort study. Blood samples were collected within 72 h after injury, and cognitive status was assessed at the 3-month follow-up. The patients were classified as mTBI without MCI (n = 80) or mTBI with MCI (n = 77). Peripheral blood cell and serum NET-related markers were measured. Multivariable logistic regression was used to identify factors independently associated with post-mTBI MCI, and receiver operating characteristic (ROC) analysis was performed to assess discrimination.
resultsCompared with HCs, patients with mTBI showed significant alterations in white blood cells, hemoglobin, platelets, neutrophil count (NEUT), lymphocytes, and eosinophils. Compared with patients without MCI, those with MCI had significantly higher levels of white blood cell count, NEUT, IL-8, IL-1β, IL-17A, IFN-α, dsDNA, myeloperoxidase (MPO), and citrullinated histone H3, but lower levels of TNF-α and vascular endothelial growth factor (VEGF). In multivariable analysis, NEUT, MPO, dsDNA, and IL-8 were independently associated with post-mTBI MCI. The combined biomarker model showed good discrimination (AUC = 0.896). DISCUSSION: Serum NET-related markers are associated with cognitive impairment after mTBI. A biomarker panel incorporating NEUT, MPO, dsDNA and IL-8 may help identify patients at increased risk of post-mTBI MCI.
Indexed as
Identifiers
42776453What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.